Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1406-1411
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1406
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1406
Factor | Univariate analysis | ||
HR | 95%CI | P value | |
TOMOX/FOLFOX | 0.877 | 0.410-1.876 | 0.736 |
Male sex | 0.915 | 0.411-2.035 | 0.827 |
Age (> 60/60 yr) | 0.758 | 0.353-1.627 | 0.477 |
Histology (poor/well and moderate) | 1.768 | 0.686-4.554 | 0.238 |
Primary tumor site (left/right hemicolon) | 0.715 | 0.285-1.797 | 0.476 |
Serum CA19-9 (high/normal) | 1.725 | 0.803-3.706 | 0.162 |
Serum CA72-4 (high/normal) | 1.325 | 0.536-3.278 | 0.542 |
Serum CEA (high/normal) | 1.339 | 0.463-3.873 | 0.590 |
Extrahepatic metastasis (present/absent) | 1.220 | 0.550-2.706 | 0.624 |
Time to liver metastasis (synchronous/metachronous) | 1.281 | 0.560-2.932 | 0.558 |
Response to TACE | 0.047 | ||
PD | 1.000 | 1.000 | |
SD | 0.275 | 0.081-0.931 | |
PR | 0.272 | 0.095-0.783 |
- Citation: Guo JH, Zhang HY, Gao S, Zhang PJ, Li XT, Chen H, Wang XD, Zhu X. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. World J Gastroenterol 2017; 23(8): 1406-1411
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1406.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1406